Rilematovir

JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.

1383450-81-4

≥ 2 years

>98% (HPLC)

500.92

C21H20ClF3N4O3S

Research use only, not for human use.

——

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-90514CL1 0.1 mL

Ask

51286091 4x 500 ng

Ask

abx913186-01 15 nmol

Ask

abx913186-02 30 nmol

Ask